• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Core Scientific Inc.

    2/1/24 4:05:38 PM ET
    $CORZ
    Finance: Consumer Services
    Finance
    Get the next $CORZ alert in real time by email
    SC 13G 1 tm244829d1_sc13g.htm SC 13G

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

      

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ____)*

      

    Core Scientific, Inc.

    (Name of Issuer)

     

    Common Stock, $0.00001 par value per share

    (Title of Class of Securities)

     

    21874A106

    (CUSIP Number)

     

    January 23, 2024

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)

     

    xRule 13d-1(c)

     

    ¨Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     Page 1 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Investors LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Colorado, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,833,690
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,833,690
    8.  SHARED DISPOSITIVE POWER 0

     

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,833,690

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 2 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Justin B. Borus

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,882,796
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,882,796
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,882,796

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.6%

     

    12.Type of Reporting Person (See Instructions)

     

    IN

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 3 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Partners (Core) LP

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Delaware, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER    4,813,877
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER    4,813,877
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,813,877

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    PN

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

      

     Page 4 of 13 Pages 

     

     

     CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex GP LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Colorado, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,813,877
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,813,877
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,813,877

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G

     

     Page 5 of 13 Pages 

     

     

     CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Investment Holdings LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Delaware, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,833,690
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,833,690
    8.  SHARED DISPOSITIVE POWER 0

      

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,833,690

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 6 of 13 Pages 

     

     

    CUSIP No. 21874A106

     

    1.Names of Reporting Persons

     

    Ibex Investment Holdings II LLC

     

    2.Check the Appropriate Box if a Member of a Group (See Instructions)

     

    (a)¨
    (b)x

     

    3.SEC Use Only

     

    4.Citizenship or Place of Organization

     

    Delaware, USA

     

    NUMBER OF SHARES
    BENEFICIALLY OWNED
    BY EACH REPORTING
    PERSON WITH:
    5.  SOLE VOTING POWER 4,813,877
    6.  SHARED VOTING POWER 0
    7.  SOLE DISPOSITIVE POWER 4,813,877
    8.  SHARED DISPOSITIVE POWER 0

       

    9.Aggregate Amount Beneficially Owned by Each Reporting Person

     

    4,813,877

     

    10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ¨

     

    11.Percent of Class Represented by Amount in Row (9)

     

    2.5%

     

    12.Type of Reporting Person (See Instructions)

     

    OO

     

    ______________

     

    The information above is given as of the end of business on February 1, 2024, the filing date of this Schedule 13G.

     

     Page 7 of 13 Pages 

     

     

    EXPLANATORY NOTE

     

    In connection with the effectiveness of the Issuer’s Chapter 11 Plan of Reorganization on January 23, 2024, the Fund received: (x) 6,571,239 shares of the Issuer’s new common stock, par value $0.00001 per share (the “Common Stock”); and (y) certain notes convertible into 4,813,877 shares of Common Stock.

     

    On January 24, 2024, the Fund declared a distribution of, and its partners became the beneficial owners of, the aforementioned 6,571,239 shares of Common Stock, including 49,106 shares that became beneficially owned by Mr. Borus and 19,813 shares that became beneficially owned by the Investment Manager.

     

    Item 1.

     

    (a)The name of the issuer is Core Scientific, Inc. (the “Issuer”).

     

    (b)The principal executive offices of the Issuer are located at 210 Barton Springs Road, Suite 300, Austin, TX 78704.

     

    Item 2.

     

    (a)

    This Schedule 13G (this “Statement” or this “Schedule 13G”) is being filed by: (1) Justin B. Borus (“Mr. Borus”); (2) Ibex Investors LLC, a Colorado limited liability company (the “Investment Manager”); (3) Ibex Partners (Core) LP, a Delaware limited partnership (the “Fund”); (4) Ibex GP LLC, a Colorado limited liability company (the “General Partner”); (5) Ibex Investment Holdings LLC, a Delaware limited liability company (“IM Holdings”); and (6) Ibex Investment Holdings II LLC, a Delaware limited liability company (“GP Holdings”) (all of the foregoing, collectively, the “Reporting Persons”).

     

    The Fund is a private investment vehicle. The Investment Manager is the investment manager of the Fund. IM Holdings is the sole member of the Investment Manager. The General Partner is the general partner of the Fund. GP Holdings is the sole member of the General Partner. Mr. Borus is the manager of the Investment Manager, IM Holdings, the General Partner and GP Holdings.

     

    The Fund directly beneficially owns the Common Stock (as defined below) reported herein (other than 49,106 shares of Common Stock owned by Mr. Borus and 19,813 shares of Common Stock owned by the Investment Manager, in each case as of the date of filing of this Schedule 13G).

     

    Mr. Borus, the Investment Manager, IM Holdings, the General Partner and GP Holdings may be deemed to beneficially own the Common Stock that is directly beneficially owned by the Fund. Mr. Borus and IM Holdings may be deemed to beneficially own the Common Stock that is directly beneficially owned by the Investment Manager.

     

    Each Reporting Person disclaims beneficial ownership with respect to any Common Stock other than the Common Stock directly beneficially owned by such Reporting Person.

     

     Page 8 of 13 Pages 

     

     

    (b)The principal business office of the Reporting Persons is c/o Ibex Investors LLC, 260 N. Josephine Street, Suite 300, Denver, CO 80206.

     

    (c)For citizenship information see Item 4 of the cover page of each Reporting Person.

     

    (d)This Statement relates to the new common stock, $0.00001 par value per share, of the Issuer (the “Common Stock”).

     

    (e)The CUSIP Number of the Common Stock is 21874A106.

     

    Item 3. If this statement is filed pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
      (b) ¨  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
      (c) ¨  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
      (d) ¨  Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
      (e) ¨  An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
      (f) ¨  An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
      (g) ¨  A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
      (h) ¨  A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
      (i) ¨  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
      (j) ¨  A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
      (k) ¨  Group, in accordance with §240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: ______________________

     

    Item 4. Ownership.

     

    See Items 5-9 and 11 on the cover page for each Reporting Person, and Item 2, which information is given as of the end of business on February 1, 2024, being the date of filing of this Schedule 13G, and consists of: (x) 4,813,877 shares of Common Stock issuable upon the conversion of certain convertible notes owned by the Fund; (y) 49,106 shares of Common Stock owned by Mr. Borus; and (z) 19,813 shares of Common Stock owned by the Investment Manager.

     

     Page 9 of 13 Pages 

     

     

    As of the end of business on the Event Date of January 23, 2024, the Fund directly beneficially owned 11,385,116 shares of Common Stock (consisting of 6,571,239 shares of Common Stock and 4,813,877 shares of Common Stock issuable upon the conversion of certain convertible notes), together representing 6.0% of all of the outstanding Common Stock.

     

    The percentages of beneficial ownership contained herein are based on: (x) 184,998,580 shares of Common Stock outstanding as of January 23, 2024, as obtained by the Reporting Persons directly form the Issuer; and (y) 4,813,877 shares of Common Stock issuable upon the conversion of the convertible notes described above.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    Not applicable.

     

    Item 8. Identification and Classification of Members of the Group.

     

    Not applicable.

     

    Item 9. Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10. Certification.

     

    (a)Not applicable.

     

    (b)Not applicable.

     

    (c)By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

     

     Page 10 of 13 Pages 

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 1, 2024

     

    Justin B. Borus

    Ibex Investors LLC

    Ibex Partners (Core) LP

    Ibex GP LLC

    Ibex Investment Holdings LLC

    Ibex Investment Holdings II LLC

     

    By: /s/ Justin B. Borus  
     

    Justin B. Borus, for himself and as the Manager of each of the Investment Manager, IM Holdings, the General Partner (for itself

    and on behalf of the Fund) and GP Holdings

     

      

     Page 11 of 13 Pages 

     

     

    EXHIBIT INDEX

     

    Exhibit No. Document

     

    1Joint Filing Agreement

     

     Page 12 of 13 Pages 

    Get the next $CORZ alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CORZ

    DatePrice TargetRatingAnalyst
    10/23/2025$23.50Neutral → Buy
    Roth Capital
    10/22/2025$30.00Neutral → Buy
    B. Riley Securities
    9/15/2025Buy
    Compass Point
    7/22/2025$20.00Buy
    Arete
    5/22/2025$15.00Mkt Outperform
    Citizens JMP
    1/27/2025$22.00Outperform
    Keefe Bruyette
    1/21/2025$24.00Buy
    Craig Hallum
    11/15/2024$25.50Buy
    ROTH MKM
    More analyst ratings

    $CORZ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Duchene Todd M covered exercise/tax liability with 8,228 shares, decreasing direct ownership by 0.41% to 2,021,428 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    10/2/25 4:30:25 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Chief Executive Officer Sullivan Adam Taylor covered exercise/tax liability with 23,508 shares, decreasing direct ownership by 0.54% to 4,363,600 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    10/2/25 4:30:01 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Officer Duchene Todd M covered exercise/tax liability with 11,805 shares, decreasing direct ownership by 0.58% to 2,029,656 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    8/19/25 4:39:42 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CoreWeave Comments on Proxy Advisor Recommendations Regarding Proposed Acquisition of Core Scientific

    CoreWeave Disagrees with the Recommendations Against the Transaction Believes the Agreed Upon Transaction Represents Fair Value of the Two Companies Urges Core Scientific Stockholders to Vote FOR the Proposed Transaction on the WHITE Proxy Card on October 30, 2025 CoreWeave Inc. (NASDAQ:CRWV), The Essential Cloud for AI, today commented on the reports published by Institutional Shareholder Services Inc. ("ISS") and Glass, Lewis & Co. ("Glass Lewis") regarding CoreWeave's definitive agreement to acquire Core Scientific, Inc. (NASDAQ:CORZ) in an all-stock transaction. CoreWeave disagrees with the recommendations to vote against this transaction. While neither ISS nor Glass Lewis quest

    10/22/25 5:03:00 PM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Second Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS In Recommending Core Scientific Shareholders Vote "AGAINST" Proposed Sale to CoreWeave on GOLD Proxy Card

    NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today welcomed the recommendations of both leading independent proxy advisory firms, Institutional Shareholder Services Inc. ("ISS") and Glass Lewis & Co., LLC ("Glass Lewis"), that shareholders of Core Scientific vote "AGAINST" the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) (the "Proposed Merger") ahead of the Company's special meeting of shareholders, which is scheduled to be held on October 30, 2025.

    10/21/25 3:00:00 PM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Leading Proxy Advisory Firm Institutional Shareholder Services Recommends Core Scientific Shareholders Vote "AGAINST" Sale to CoreWeave on GOLD Proxy Card

    ISS Highlights Numerous Concerns Regarding the Sale Process, Deal Structure and Valuation Agrees with Two Seas That the Board's Flawed Process Did Not Maximize Value for Shareholders NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today applauded leading independent proxy advisory firm Institutional Shareholder Services Inc.'s ("ISS") recommendation that shareholders of Core Scientific vote "AGAINST" the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7

    10/21/25 9:05:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CORZ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CORZ
    SEC Filings

    View All

    $CORZ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Core Scientific upgraded by Roth Capital with a new price target

    Roth Capital upgraded Core Scientific from Neutral to Buy and set a new price target of $23.50

    10/23/25 6:59:02 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific upgraded by B. Riley Securities with a new price target

    B. Riley Securities upgraded Core Scientific from Neutral to Buy and set a new price target of $30.00

    10/22/25 8:06:41 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Compass Point resumed coverage on Core Scientific

    Compass Point resumed coverage of Core Scientific with a rating of Buy

    9/15/25 7:53:27 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form 425 filed by Core Scientific Inc.

    425 - Core Scientific, Inc./tx (0001839341) (Subject)

    10/22/25 5:20:52 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific Inc. filed SEC Form 8-K: Other Events

    8-K - Core Scientific, Inc./tx (0001839341) (Filer)

    10/22/25 4:44:46 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form 425 filed by Core Scientific Inc.

    425 - Core Scientific, Inc./tx (0001839341) (Subject)

    10/22/25 4:44:47 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Rozov Yadin bought $1,195,370 worth of shares (110,000 units at $10.87), increasing direct ownership by 30% to 475,687 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    5/29/25 4:14:21 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Weiss Eric Stanton bought $50,750 worth of shares (6,000 units at $8.46), increasing direct ownership by 3% to 221,687 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/7/25 3:07:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Director Levy Jordan bought $500,506 worth of shares (62,500 units at $8.01), increasing direct ownership by 26% to 306,887 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/6/25 6:45:04 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Leadership Updates

    Live Leadership Updates

    View All

    /C O R R E C T I O N -- Two Seas Capital/

    In the news release, Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave, issued 17-Oct-2025 by Two Seas Capital over PR Newswire, three charts were inadvertently excluded by PR Newswire. The release, with the accompanying charts and the full pdf letter, follows: Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW

    10/17/25 9:00:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Two Seas Capital Highlights Significant Value Upside for Core Scientific Shareholders If They Reject the Proposed Sale to CoreWeave

    Issues Letter to Shareholders Citing Market Evidence Demonstrating the Proposed Transaction Substantially Undervalues Core Scientific Urges Shareholders to Vote AGAINST the Proposed Transaction on the GOLD Proxy Card NEW YORK, Oct. 17, 2025 /PRNewswire/ -- Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and one of the largest shareholders of Core Scientific, Inc. ("Core Scientific" or the "Company") (NASDAQ:CORZ), today issued a letter to shareholders in connection with its opposition to the Company's proposed sale to CoreWeave, Inc. ("CoreWeave") (NASDAQ:CRWV) on the terms announced on July 7, 2025.

    10/17/25 9:00:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    Xobee Networks Announces Appointment of Scott Brueggeman as Chief Revenue Officer

    O2 Investment Partners (www.o2investment.com) is pleased to announce that Xobee Networks (www.xobee.com), a leading managed service provider, has appointed Scott Brueggeman as its Chief Revenue Officer. Mr. Brueggeman brings more than 25 years of leadership experience across technology, infrastructure, and business services companies, with a particular focus on sales, marketing, and go-to-market strategy. Most recently, he served as Chief Marketing Officer at Core Scientific (NASDAQ:CORZ), where he led the company's strategic pivot into AI-driven high-performance computing infrastructure. Prior to that, he held senior executive roles at Logix Fiber Networks, CyrusOne, and CoreLink Data Ce

    6/30/25 6:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $CORZ
    Financials

    Live finance-specific insights

    View All

    Core Scientific Announces Fiscal Second Quarter 2025 Results

    Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and digital asset mining, today announced financial results for the fiscal second quarter of 2025. Fiscal Second Quarter 2025 Financial Results Total revenue was $78.6 million compared to $141.1 million in the second quarter of 2024. Digital asset self-mining revenue was $62.4 million, down from $110.7 million in the prior-year period. The decline was primarily driven by a 62% decrease in bitcoin mined, partially offset by a 50% increase in the average bitcoin price. Digital asset hosted mining revenue was $5.6 million, down from $24.8 million in the same period a year ago.

    8/8/25 4:10:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Core Scientific, Inc. Schedules Second Quarter Fiscal Year 2025 Earnings Release Date

    Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services and bitcoin mining, today announced it will release its second quarter fiscal year 2025 financial results after financial markets close on Friday, August 8, 2025. Due to the pending transaction with CoreWeave, Inc., which was previously announced on July 7, 2025, the Company will not be hosting a conference call or webcast to discuss its second quarter fiscal year 2025 results. About Core Scientific, Inc. Core Scientific, Inc. ("Core Scientific" or the "Company") is a leader in digital infrastructure for high-density colocation services and digital asset mining. We operate dedi

    8/6/25 4:17:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    CoreWeave to Acquire Core Scientific

    Verticalizes Data Center Ownership to Help Future-Proof Revenue Growth and Enhance Core Profitability CoreWeave (NASDAQ:CRWV), the AI Hyperscaler™, and Core Scientific (NASDAQ:CORZ), a leading data center infrastructure provider, today announced that they have signed a definitive agreement under which CoreWeave will acquire Core Scientific in an all-stock transaction. Under the terms of the merger agreement, Core Scientific stockholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock based on a fixed exchange ratio. Following CoreWeave's successful IPO in March 2025, this acquisition will help CoreWeave verticalize i

    7/7/25 8:27:00 AM ET
    $CORZ
    $CRWV
    Finance: Consumer Services
    Finance
    Computer Software: Prepackaged Software
    Technology

    $CORZ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Core Scientific Inc.

    SC 13G - Core Scientific, Inc./tx (0001839341) (Subject)

    8/19/24 7:14:21 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

    SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    2/21/24 4:43:56 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    SEC Form SC 13D/A filed by Core Scientific Inc. (Amendment)

    SC 13D/A - Core Scientific, Inc./tx (0001839341) (Subject)

    2/20/24 5:19:03 PM ET
    $CORZ
    Finance: Consumer Services
    Finance